Besiktas, Turkey

Maide Nur Paksoy

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignees: Bahçesehir Üniversitesi, Istanbul Teknik Üniversitesi. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maide Nur Paksoy. Retrieved from https://idiyas.com/inventor/maide-nur-paksoy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 33.3

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Maide Nur Paksoy: Innovator in MDM2 Inhibition

Introduction

Maide Nur Paksoy is a prominent inventor based in Besiktas, Turkey. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel inhibitors for cancer treatment. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical research.

Latest Patents

Maide Nur Paksoy holds a patent for the compound DRG-MDM2-6, which serves as a novel mouse double minute 2 (MDM2) inhibitor. This invention relates to a compound represented by a specific formula or its pharmaceutically acceptable derivatives, aimed at inhibiting MDM2 activity. This breakthrough has the potential to impact cancer therapies significantly.

Career Highlights

Throughout her career, Maide has worked with esteemed institutions such as Bahçesehir University and Istanbul Technical University. Her roles in these organizations have allowed her to engage in cutting-edge research and collaborate with other experts in her field.

Collaborations

Maide has collaborated with notable colleagues, including Serdar Durdagi and Timucin Avsar. These partnerships have enriched her research and contributed to her success as an inventor.

Conclusion

Maide Nur Paksoy is a trailblazer in the field of pharmaceutical innovation, with her patent for MDM2 inhibition marking a significant milestone in cancer research. Her contributions continue to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…